Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin de Bock

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Diabetes Technology & Therapeutics|April 13, 2023
Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring SystemMary B Abraham, Grant J Smith, Ace Y L Choo, et al.
The New Zealand Medical Journal|April 11, 2024
Intensive management from diagnosis improves HbA1c at 12 months post-diagnosis: results from a prospective cohort study in children with newly diagnosed type 1 diabetesCaroline Griffin, Erin Roxburgh, Neil Owens, et al.
Peerj|July 18, 2018
Socioeconomic status is not associated with health-related quality of life in a group of overweight middle-aged menJosé G B Derraik, Benjamin B Albert, Martin de Bock, et al.
Molecular Nutrition & Food Research|June 15, 2013
Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extractMartin de Bock, Eric B Thorstensen, José G B Derraik, et al.
Diabetes Technology & Therapeutics|January 9, 2019
Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 DiabetesMarie-Anne Burckhardt, Tarini Chetty, Grant J Smith, et al.
Journal of Paediatrics and Child Health|January 28, 2023
Prevalence and incidence of type 1 diabetes in children aged 0-14 years old in New Zealand in 2021Rachel Wu, Mercedes Burnside, Hannah Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 2, 2023
Do-it-yourself continuous glucose monitoring in people aged 16 to 69 years with type 1 diabetes: A qualitative studyShekhar Sehgal, Alisa Boucsein, Sara Styles, et al.
Pediatric Diabetes|July 25, 2018
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologiesJennifer L Sherr, Martin Tauschmann, Tadej Battelino, et al.
Journal of Diabetes and Metabolic Disorders|August 25, 2020
CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetesM Burnside, D Lewis, H Crocket, et al.
Pediatric Diabetes|December 20, 2022
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetesMartin de Bock, Ethel Codner, Maria E Craig, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|April 13, 2023
Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring SystemMary B Abraham, Grant J Smith, Ace Y L Choo, et al.
The New Zealand Medical Journal|April 11, 2024
Intensive management from diagnosis improves HbA1c at 12 months post-diagnosis: results from a prospective cohort study in children with newly diagnosed type 1 diabetesCaroline Griffin, Erin Roxburgh, Neil Owens, et al.
Peerj|July 18, 2018
Socioeconomic status is not associated with health-related quality of life in a group of overweight middle-aged menJosé G B Derraik, Benjamin B Albert, Martin de Bock, et al.
Molecular Nutrition & Food Research|June 15, 2013
Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extractMartin de Bock, Eric B Thorstensen, José G B Derraik, et al.
Diabetes Technology & Therapeutics|January 9, 2019
Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 DiabetesMarie-Anne Burckhardt, Tarini Chetty, Grant J Smith, et al.
Journal of Paediatrics and Child Health|January 28, 2023
Prevalence and incidence of type 1 diabetes in children aged 0-14 years old in New Zealand in 2021Rachel Wu, Mercedes Burnside, Hannah Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 2, 2023
Do-it-yourself continuous glucose monitoring in people aged 16 to 69 years with type 1 diabetes: A qualitative studyShekhar Sehgal, Alisa Boucsein, Sara Styles, et al.
Pediatric Diabetes|July 25, 2018
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologiesJennifer L Sherr, Martin Tauschmann, Tadej Battelino, et al.
Journal of Diabetes and Metabolic Disorders|August 25, 2020
CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetesM Burnside, D Lewis, H Crocket, et al.
Pediatric Diabetes|December 20, 2022
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetesMartin de Bock, Ethel Codner, Maria E Craig, et al.
Pageof 9